Acorda Therapeutics, Inc.
ACOR
Revenue
20.29M
▼-17.70M▼-46.59%
3 Months ChangeAssets
81.58M
▼-26.95M▼-24.83%
3 Months ChangeLiabilities
267.35M
▲865.00k▲0.3246%
3 Months ChangeFree Cash Flow
-13.68M
▲13.24M▲49.19%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-06-25
Form 8-K
ID: 0000950170-24-076941
2024-06-12
Form 8-K
ID: 0000950170-24-072511
2024-06-04
Form 8-K
ID: 0000950170-24-068750
2024-05-24
Form 8-K
ID: 0000950170-24-064311
2024-05-14
Form 10-Q
ID: 0000950170-24-059114
2024-04-26
Form 8-K
ID: 0000950170-24-048583
2024-04-17
Form 8-K
ID: 0000950170-24-044938
2024-04-04
Form 8-K
ID: 0000950170-24-041350
2024-04-02
Form 8-K
ID: 0000950170-24-039674
2024-03-13
Form 8-K
ID: 0000950170-24-030816